MEB 12.5% 0.9¢ medibio limited

249D to fail

  1. 926 Posts.
    lightbulb Created with Sketch. 48

    Looks like the market is responding to the roadshow that Brian Mower undertook with major shareholders over course of last week. I hear they were pleased to hear of the calibre of new CEO's being considered and that the support for the 249D seems to be very thin. With $3m into the bank this week from the rebate, there will be plenty of options for funding, #notdesperate. Perhaps buying here under 6c could be very profitable for the brave.

    DYOR
    R

 
watchlist Created with Sketch. Add MEB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.